权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

EUthyroid2 - The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe

EU甲状腺2 - 欧洲消除碘缺乏症和可预防的碘相关疾病的下一步

基本信息

批准号：
10062205
负责人：
金额：
$ 31.94万
依托单位：
UNIVERSITY OF SURREY
依托单位国家：
英国
项目类别：
EU-Funded
财政年份：
2023
资助国家：
英国
起止时间：
2023 至无数据
项目状态：
未结题

来源：
https://gtr.ukri.org/projects?ref=10062205
关键词：
EUthyroid2 next step towards elimination

项目摘要

The iodine status is a primary determinant of thyroid disorders, which are a major cause of morbidity, particularly in women. In addition, even mild-to-moderate iodine deficiency during pregnancy is related to neurocognitive impairment in the offspring. Iodine deficiency imposes tremendous costs on the health-care systems of affected regions, but can easily be prevented by iodine fortification programmes. In many countries, iodine deficiency receives surprisingly little publicity. The initial EUthyroid consortium evaluated European prevention programmes against iodine deficiency and uncovered major limitations including the low awareness on the importance of iodine for healthy living. EUthyroid2 will now fill important gaps in the prevention of iodine deficiency in Europe and beyond. The main objective of EUthyroid2 is to improve the low awareness with respect to iodine deficiency-related risks in adolescents and young women. The major aim is to find best practice models for accessing and informing them to increase their awareness and to improve their iodine status in order to lay the foundation for their own thyroid and general health and that of their offspring. Implementation studies and community-based randomised-controlled trials will be conducted with the objective of increasing iodinerelated awareness in adolescents and young women up to age of 24 before pregnancy. The interventions are multimodal and performed in the two settings educational system and ambulatory care in eight study regions. As public health project EUthyroid2 is not only science, but will also serve our societies. Therefore, dissemination of findings to various sectors of our countries and the EU will be of utmost importance. By finding best practice models to raise the awareness on the importance of iodine for a healthy life of their own and their offspring in young people, EUthyroid2 will lay the foundation for a cost-effective way to eradicate iodine deficiency-related disorders.

碘的状况是甲状腺疾病的主要决定因素，而甲状腺疾病是发病的主要原因，特别是在妇女中。此外，即使是怀孕期间轻度至中度的碘缺乏也与后代的神经认知障碍有关。碘缺乏症给受影响地区的卫生保健系统带来巨大成本，但可以通过碘强化规划轻松预防。在许多国家，碘缺乏症得到的宣传少得惊人。最初的欧盟甲状腺联盟评估了欧洲预防碘缺乏症的方案，发现了主要的局限性，包括对碘对健康生活的重要性认识不足。EUthyroid2现在将填补欧洲和其他地区在预防碘缺乏症方面的重要空白。EUthyroid2的主要目标是改善青少年和年轻妇女对碘缺乏相关风险的低认识。主要目的是寻找最佳做法模式，使她们能够获得和了解碘，提高她们的认识，改善她们的碘状况，为她们自己及其后代的甲状腺和一般健康奠定基础。将进行实施研究和以社区为基础的随机对照试验，目的是提高怀孕前24岁以下青少年和年轻妇女对碘的认识。干预措施是多模式的，在八个研究区域的两种设置教育系统和门诊护理中进行。作为公共卫生项目，EUthyroid2不仅是科学，而且将服务于我们的社会。因此，向我们各国和欧盟的各个部门传播调查结果将是极为重要的。EUthyroid2通过寻找最佳实践模式，提高年轻人对碘对自己及其后代健康生活重要性的认识，将为以具有成本效益的方式根除碘缺乏相关疾病奠定基础。